Historically, medium-priority insider buys have outperformed the S&P 500 by a median ~1% over the 30 days after filing — the edge is concentrated in that first month (n ≈ 7,520, 2022-2026). Past results don't predict the future. How we measure this ↗
CEO Cole Lecil E bought 38,155 shares of CVGW at $24.60 (April 14); stock +11.0% in 30 days as cluster emerges.
CEO Cole Lecil E purchased 38,155 shares at $24.60 on 2025-04-14, increasing his holdings by 7.1% to 574,225 shares. The timing aligns with a broader cluster pattern: 2 other insiders also bought within the past 14 days. The stock has since risen 11.0% over the 30-day period following the transaction. However, contextual headwinds are material: the company reported annual revenue growth of -31.9%, full-year net income was negative, and the P/E stands at 48.46, reflecting elevated valuation despite depressed profitability. The CEO's prior CVGW-specific buy transactions from 2023 showed mixed 90-day outcomes (-15.7% and -12.6%), and his cross-ticker history reflects a 0.00% 90-day win rate across 4 prior buys, suggesting prior large positions did not appreciate materially beyond the first month.
CVGW CEO Cole Lecil E bought 40,775 shares at $24.57 on 2025-04-15; cluster buy with 2 other insiders in 14 days.
Cole Lecil E, Chief Executive Officer of Calavo Growers Inc, purchased 40,775 shares at $24.57 for $1,001,841.75 on 2025-04-15, adding 7.1% to his position (615.0K shares post-transaction). This purchase occurred as part of a cluster pattern with 2 other insiders buying within the same 14-day window. However, the company's fundamentals present a mixed picture: annual revenue growth was -31.9%, the company reported negative full-year net income, and the current P/E ratio stands at 48.46. His own prior trades at CVGW showed a 90-day win rate of 0.00% (0 of 2 prior buys were well-timed, with 90-day returns of -15.7% and -12.6%), and his cross-ticker track record shows an average 90-day return of -14.2%. While the stock has risen 11.0% over the past 30 days, this buy occurred at a discount to the 52-week high ($29.64) yet in an environment of company-level revenue contraction and unprofitability.
CEO Cole Lecil buys 21,070 shares at $23.73; part of cluster with 2 other insiders buying in past 14 days
Cole Lecil, Chief Executive Officer, purchased 21,070 shares at $23.73, bringing his holdings to 536,070 shares. This transaction occurs as part of a cluster pattern with 2 other insiders also buying within the past 14 days. Lecil's prior trades at CVGW show mixed timing: his 2023 purchases generated +20.6% and +23.8% 30-day returns but declined -15.7% and -12.6% over 90 days, with a 0.00% 90-day win rate across those measurable outcomes. The company's fundamentals present headwinds—annual revenue declined 31.9% year-over-year, the firm was unprofitable over its most recent full fiscal year, and the stock trades at a P/E of 44.63 despite only $4.4M net income on $154.4M quarterly revenue. Current price of $24.10 sits 18.7% below the 52-week high of $29.64, having recovered +4.1% over the past 30 days but still down 7.0% over 90 days.
Browne (EVP) buys 5,000 shares of CVGW at $23.12; holdings increase 357.1%; stock down -23.3% from 52-week high.
Browne purchased 5,000 shares at $23.12, increasing his position from 1,400 to 6,400 shares (a 357.1% expansion). The purchase occurs at a price 23.3% below the 52-week high of $29.64, and just 1.6% above the 30-day low. However, his prior four purchases at Calavo on 2023-09-18 each generated negative 90-day returns (−4.6% to −4.5%), and none of his three measurable same-ticker buys have produced positive 90-day outcomes. The company reported full-year net income negative and revenue declined 31.9% year-over-year, while the current P/E of 42.11 reflects a stretched valuation despite near-zero profitability. The purchase lacks demonstrable timing success at this ticker and occurs amid deteriorating fundamentals.
CFO James E Snyder purchases 3,213 shares of CVGW for $74,959.29 at $23.33, raising holdings 165.3%
CFO James E Snyder executed a substantial purchase of 3,213 shares at $23.33, raising his total holdings from 1,944 to 5,157 shares—a 165.3% increase in his position. The timing occurs as CALAVO's stock trades 23.3% below its 52-week high of $29.64, while the company faces material headwinds: annual revenue declined 31.9%, the company posted negative full-year net income despite recent quarterly profitability of $4.4M, and the P/E multiple of 42.11 remains elevated relative to peers. This inside purchase by the CFO at a depressed valuation suggests management's assessment of fundamental value despite the company's recent profitability challenges.
CVGW EVP Browne Michael A acquired 6,000 shares at $23.69; post-transaction holdings 7,500 shares (+400.0%)
Michael A Browne, Executive Vice President, purchased 6,000 shares of CALAVO GROWERS INC at $23.69 on 2025-04-02, quadrupling his prior holding from 1,500 to 7,500 shares. His cross-ticker track record shows 3 prior buys with an average 90-day return of -1.9% and a 0.00% win rate, and at this same ticker, all 3 prior purchases (in September 2023) generated negative 90-day returns of -1.8% and -1.9%. The company faces significant headwinds: annual revenue growth declined -31.9%, it was unprofitable over the full fiscal year, and it trades at a P/E of 44.19 while the stock is -19.5% from its 52-week high. The substantial share purchase magnitude contrasts sharply with this insider's historical pattern of unsuccessful buy timing and the company's deteriorating financial trajectory.
Add CVGW to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.